AlloDx Presents Products and Research at CSOT 2018

The 2018 Organ Transplantation Annual Conference of the Chinese Medical Association was held from October 26 to 28, 2018, at the Yanqi Lake International Convention and Exhibition Center in Beijing.

A total of 4 of the company's latest scientific research results in the field of transplantation liquid biopsy were unveiled at the conference, and were invited to give keynote reports at the conference together with cooperative units. Among them, the project report "Application of ddcfDNA in the Diagnosis and Treatment Effect Evaluation of Acute Rejection After Kidney Transplantation" is the first domestic display of research results in the direction of non-invasive rejection detection, and provides a technical platform and data support for the application of non-invasive rejection detection in Chinese transplant patients. The three research results of "High-throughput Pathogenic Microorganism Detection Platform", "Dynamic Monitoring of ddcfDNA Concentration in the Early Post-Kidney Transplantation" and "Establishment of a Quantitative ddcfDNA Model Independent of Donor Genotype" were all reported at the Transplantation Pathology and Transplantation Infection session, and received active attention and unanimous recognition from the participating experts.

The Chinese Medical Association Organ Transplantation Annual Conference and the Chinese Organ Transplant Physicians Annual Conference are currently the most authoritative organ transplantation academic organizations in the country. The Organ Transplantation Annual Meeting held by the Chinese Medical Association of CSOT is the highest-level national academic event in the field of organ transplantation in my country. Each meeting is a stage for elites from all aspects of the organ transplantation field to showcase their talents.

AlloDx (AlloDx) focuses on the post-organ transplant rehabilitation market. Since its establishment, the company's team has been deeply involved in the field of transplant rejection and pathogenic infection detection, and has initially built a database of rejection and pathogenic infection for China's transplant population. In order to actively exchange research results with top domestic transplantation experts and colleagues, Marketing Director Dr. Ge Jun, along with nearly ten people from the marketing and medical teams, as well as Professor Zhou Yang from the Jiangnan University Organ Transplantation Institute, attended the CSOT event.

The 2018 CSOT conference has come to an end, and the fruitful results guide us on a new journey. It is believed that in the near future, through accurate diagnosis, transplant patients will have longer quality of life and survival after surgery, and clinical treatments will be more accurate and effective. We have been working hard for the happiness of organ transplant patients and their families!